Reported Impact of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy on Systemic Toxicity
β Scribed by Paul H. Sugarbaker
- Book ID
- 111772379
- Publisher
- Springer
- Year
- 2008
- Tongue
- English
- Weight
- 150 KB
- Volume
- 15
- Category
- Article
- ISSN
- 1068-9265
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract ## Background and Objectives Failure to respond to systemic chemotherapy is considered an exclusion criterion by some institutions for treatment with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC). However, it is unknown if these patients benefit from HIPEC
## Abstract ## Background and Objectives Cytoreduction with hyperthermic intraβperitoneal chemotherapy (HIPEC) is a treatment with a high morbidity. Optimal patients selection can possible reduce toxicity and complications. ## Patients and Methods Complications and toxicity of 102 patients were